Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020
ASSETS
Total Assets
Current Liabilities:
Accounts payable	326,400	326,400
Accrued liabilities	1,114,002	1,150,820
Accrued officer compensation	352,000	292,000
Convertible Notes, net of discounts of $69,993 and $77,004, respectively	1,045,319	1,391,432
Derivative liabilities		2,140,159
Put premium on stock settled debt	656,730
Loans payable	254,500	254,500
Total Current Liabilities	3,748,950	5,555,311
Total Liabilities	3,493,098	5,555,311
Commitments and Contingencies (Note 12)
STOCKHOLDERS’ DEFICIT:
Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 shares issued and outstanding	33,815	33,815
Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 shares issued and outstanding	50	50
Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 shares issued and outstanding	50,000	50,000
Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 shares issued and outstanding	12	12
Series E Preferred stock, 500,000 shares authorized, par value $0.01; - and 34,985 shares issued and outstanding; respectively		34,985
Series E Preferred stock to be issued	166,331	140,831
Common stock 3,000,000,000 shares authorized, $0.00001 par value; 3,701,732,545 and 1,339,044,282 shares issued and outstanding, respectively at June 30, 2021 and December 31, 2020	37,017	13,390
Treasury stock, at cost – 2,917 shares	(773,500)	(773,500)
Additional paid in capital	78,970,365	76,679,297
Accumulated deficit	(82,233,041)	(81,759,691)
Total Stockholders’ Deficit	(3,493,098)	(5,555,311)
Total Liabilities and Stockholders’ Deficit